Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autocrine stimulation of P2Y1 receptors is part of the purinergic signaling mechanism that regulates T cell activation
Tobias Woehrle, Carola Ledderose, Jessica Rink, et al.
Purinergic Signalling (2019) Vol. 15, Iss. 2, pp. 127-137
Open Access | Times Cited: 20

Showing 20 citing articles:

Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities
Ping Wang, Jidong Jia, Dong Zhang
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100165-100165
Open Access | Times Cited: 34
Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis
Rui Li, Yanting Lei, Ayman Rezk, et al.
Science Immunology (2024) Vol. 9, Iss. 95
Closed Access | Times Cited: 4
γδ T cells cultured with artificial antigen-presenting cells and IL-2 show long-term proliferation and enhanced effector functions compared with γδ T cells cultured with only IL-2 after stimulation with zoledronic acid
Haeyoun Choi, Yunkyung Lee, Gaeun Hur, et al.
Cytotherapy (2021) Vol. 23, Iss. 10, pp. 908-917
Closed Access | Times Cited: 19
Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics
Yanshuo Guo, Tianqi Mao, Yafei Fang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Frontline Science: P2Y11 receptors support T cell activation by directing mitochondrial trafficking to the immune synapse
Carola Ledderose, Sophie Bromberger, Christian J. Slubowski, et al.
Journal of Leukocyte Biology (2020) Vol. 109, Iss. 3, pp. 497-508
Open Access | Times Cited: 18
PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis
Lingling Bao, Kai Sun, Xuede Zhang
Channels (2021) Vol. 15, Iss. 1, pp. 680-696
Open Access | Times Cited: 17
The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis
Chakib Hamoudi, Chenqi Zhao, Amna Abderrazak, et al.
The Journal of Immunology (2022) Vol. 208, Iss. 5, pp. 1115-1127
Open Access | Times Cited: 11
P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failure
Biliana Marcheva, Benjamin J. Weidemann, Akihiko Taguchi, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 10
P2Y1R Ligation Suppresses Th17 Cell Differentiation and Alleviates Colonic Inflammation in an AMPK-Dependent Manner
Yaoyao Chang, Qiu-Chan Huan, Jiao Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells
Valentina Vultaggio-Poma, Francesco Di Virgilio
Biomolecules (2022) Vol. 12, Iss. 7, pp. 983-983
Open Access | Times Cited: 8
P2Y purinergic signaling in prostate cancer: Emerging insights into pathophysiology and therapy
Mahmoud G. Khalafalla, Tran N. Hung, Farid G. Khalafalla
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188732-188732
Closed Access | Times Cited: 7
Characteristics and the role of purinergic receptors in pathophysiology with focus on immune response
Marharyta Zyma, Rafał Pawliczak
International Reviews of Immunology (2020) Vol. 39, Iss. 3, pp. 97-117
Closed Access | Times Cited: 9
β1 Integrin induces adhesion and migration of human Th17 cells via Pyk2‐dependent activation of P2X4 receptor
Chakib Hamoudi, Abbas Muheidli, Fawzi Aoudjit
Immunology (2022) Vol. 168, Iss. 1, pp. 83-95
Open Access | Times Cited: 5
Sex-related differences in the response of anti-platelet drug therapies targeting purinergic signaling pathways in sepsis
Emmanuel Boadi Amoafo, Philomena Entsie, Samara Albayati, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Functional Characterization of HIC, a P2Y1 agonist, As a p53 Stabilizer for Prostate Cancer Cell Death Induction
Hien Thi Thu Le, Akshaya Murugesan, Nuno R. Candeias, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 21, pp. 1845-1864
Closed Access | Times Cited: 4
Editorial overview: “Purinergic immune cell regulation reveals novel pharmacological targets”
Wolfgang G. Junger, Carola Ledderose
Current Opinion in Pharmacology (2024) Vol. 75, pp. 102435-102435
Open Access
Extracellular Purine Metabolism—Potential Target in Multiple Sclerosis
Danijela Laketa, Irena Lavrnja
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8361-8386
Closed Access
Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases
Richa Rai
Biochemistry (2022)
Open Access | Times Cited: 1
Establishing a novel and sensitive assay for bioactivity determination of anti-CD25 antibodies
Maoqin Duan, Chuanfei Yu, Yalan Yang, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17401-e17401
Open Access
Pharmacologic rescue of circadian β-cell failure through P2Y1 purinergic receptor identified by small-molecule screen
Biliana Marcheva, Benjamin J. Weidemann, Akihiko Taguchi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top